Cargando…

Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units

Background: Circulating CD34+ progenitor cells (CD34+CPCs) are characterized by pronounced tissue regeneration activity. Dyslipidemic subjects seemed to have reduced CD34+CPCs, and statin therapy appeared to restore their levels. We aimed to evaluate the effects of PCSK9 inhibitors (PCSK9-i) on CD34...

Descripción completa

Detalles Bibliográficos
Autores principales: Scicali, Roberto, Mandraffino, Giuseppe, Scuruchi, Michele, Lo Gullo, Alberto, Di Pino, Antonino, Ferrara, Viviana, Morace, Carmela, Aragona, Caterina Oriana, Squadrito, Giovanni, Purrello, Francesco, Piro, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312801/
https://www.ncbi.nlm.nih.gov/pubmed/35885020
http://dx.doi.org/10.3390/biomedicines10071715
_version_ 1784753921559887872
author Scicali, Roberto
Mandraffino, Giuseppe
Scuruchi, Michele
Lo Gullo, Alberto
Di Pino, Antonino
Ferrara, Viviana
Morace, Carmela
Aragona, Caterina Oriana
Squadrito, Giovanni
Purrello, Francesco
Piro, Salvatore
author_facet Scicali, Roberto
Mandraffino, Giuseppe
Scuruchi, Michele
Lo Gullo, Alberto
Di Pino, Antonino
Ferrara, Viviana
Morace, Carmela
Aragona, Caterina Oriana
Squadrito, Giovanni
Purrello, Francesco
Piro, Salvatore
author_sort Scicali, Roberto
collection PubMed
description Background: Circulating CD34+ progenitor cells (CD34+CPCs) are characterized by pronounced tissue regeneration activity. Dyslipidemic subjects seemed to have reduced CD34+CPCs, and statin therapy appeared to restore their levels. We aimed to evaluate the effects of PCSK9 inhibitors (PCSK9-i) on CD34+CPCs and pulse wave velocity (PWV) in a cohort of heterozygous familial hypercholesterolemia (HeFH) subjects. Methods: We determined CD34+ cell count and its change after PCSK9-i in 30 selected HeFH subjects and 30 healthy controls. Lipid profile and PWV were evaluated at baseline (T0), 6 months after intensive lipid lowering strategy (statin plus ezetimibe, T1), and after 6 months of optimized therapy with PCSK9-i (T2); CD34+ cell count was reported at T1 and T2. Results: At T1, the median value of CD34+ cells was not significantly different between HeFH subjects and controls, and the same result was obtained at T2. PWV was significantly reduced at T1 (ΔPWV − 14.8%, p < 0.001 vs. T0) and T2 (ΔPWV − 10.96%, p < 0.001 vs. T1). Dividing HeFH subjects into two groups of high- and low-CD34+ cell count, CD34+CPCs appeared to be polarized with a significant difference between the two groups (1.2 (0.46) vs. 4.74 (1.92), p < 0.001), also with respect to controls (both p < 0.001). This polarization was no longer observed at T2, and neither with respect to controls. ΔCD34+ was +67.4% in the low-CD34+ group and −39.24% in the high-CD34+ group (p < 0.001). Lastly, we found a significant correlation between ΔCD34+ cell number and ΔPWV in HeFH subjects (rho = −0.365, p < 0.05), particularly in the low-CD34+ group (rho = −0.681, p < 0.001). Conclusion: PCSK9-i exhibited favorable effects on CD34 + CPCs as was on PWV values in a cohort of FH subjects. Our preliminary findings suggest a possible positive role of this novel lipid-lowering strategy on vascular homeostasis.
format Online
Article
Text
id pubmed-9312801
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93128012022-07-26 Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units Scicali, Roberto Mandraffino, Giuseppe Scuruchi, Michele Lo Gullo, Alberto Di Pino, Antonino Ferrara, Viviana Morace, Carmela Aragona, Caterina Oriana Squadrito, Giovanni Purrello, Francesco Piro, Salvatore Biomedicines Article Background: Circulating CD34+ progenitor cells (CD34+CPCs) are characterized by pronounced tissue regeneration activity. Dyslipidemic subjects seemed to have reduced CD34+CPCs, and statin therapy appeared to restore their levels. We aimed to evaluate the effects of PCSK9 inhibitors (PCSK9-i) on CD34+CPCs and pulse wave velocity (PWV) in a cohort of heterozygous familial hypercholesterolemia (HeFH) subjects. Methods: We determined CD34+ cell count and its change after PCSK9-i in 30 selected HeFH subjects and 30 healthy controls. Lipid profile and PWV were evaluated at baseline (T0), 6 months after intensive lipid lowering strategy (statin plus ezetimibe, T1), and after 6 months of optimized therapy with PCSK9-i (T2); CD34+ cell count was reported at T1 and T2. Results: At T1, the median value of CD34+ cells was not significantly different between HeFH subjects and controls, and the same result was obtained at T2. PWV was significantly reduced at T1 (ΔPWV − 14.8%, p < 0.001 vs. T0) and T2 (ΔPWV − 10.96%, p < 0.001 vs. T1). Dividing HeFH subjects into two groups of high- and low-CD34+ cell count, CD34+CPCs appeared to be polarized with a significant difference between the two groups (1.2 (0.46) vs. 4.74 (1.92), p < 0.001), also with respect to controls (both p < 0.001). This polarization was no longer observed at T2, and neither with respect to controls. ΔCD34+ was +67.4% in the low-CD34+ group and −39.24% in the high-CD34+ group (p < 0.001). Lastly, we found a significant correlation between ΔCD34+ cell number and ΔPWV in HeFH subjects (rho = −0.365, p < 0.05), particularly in the low-CD34+ group (rho = −0.681, p < 0.001). Conclusion: PCSK9-i exhibited favorable effects on CD34 + CPCs as was on PWV values in a cohort of FH subjects. Our preliminary findings suggest a possible positive role of this novel lipid-lowering strategy on vascular homeostasis. MDPI 2022-07-15 /pmc/articles/PMC9312801/ /pubmed/35885020 http://dx.doi.org/10.3390/biomedicines10071715 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Scicali, Roberto
Mandraffino, Giuseppe
Scuruchi, Michele
Lo Gullo, Alberto
Di Pino, Antonino
Ferrara, Viviana
Morace, Carmela
Aragona, Caterina Oriana
Squadrito, Giovanni
Purrello, Francesco
Piro, Salvatore
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units
title Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units
title_full Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units
title_fullStr Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units
title_full_unstemmed Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units
title_short Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units
title_sort effects of lipid lowering therapy optimization by pcsk9 inhibitors on circulating cd34+ cells and pulse wave velocity in familial hypercholesterolemia subjects without atherosclerotic cardiovascular disease: real-world data from two lipid units
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312801/
https://www.ncbi.nlm.nih.gov/pubmed/35885020
http://dx.doi.org/10.3390/biomedicines10071715
work_keys_str_mv AT scicaliroberto effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits
AT mandraffinogiuseppe effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits
AT scuruchimichele effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits
AT logulloalberto effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits
AT dipinoantonino effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits
AT ferraraviviana effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits
AT moracecarmela effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits
AT aragonacaterinaoriana effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits
AT squadritogiovanni effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits
AT purrellofrancesco effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits
AT pirosalvatore effectsoflipidloweringtherapyoptimizationbypcsk9inhibitorsoncirculatingcd34cellsandpulsewavevelocityinfamilialhypercholesterolemiasubjectswithoutatheroscleroticcardiovasculardiseaserealworlddatafromtwolipidunits